NSE filing, NSE: CONNPLEX. Summary written from the filing by ALFA Finder's alert engine.
Connplex Cinemas Ltd: key numbers
- Share price
- ₹236.35
- Market cap
- ₹451.4 Cr
- Revenue (annual)
- ₹147.5 Cr
- Net profit (annual)
- ₹26.08 Cr
- P/E (TTM)
- 17.3×Sector 28.1×
- Promoter holding
- 68.41%
- FII holding
- 0.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Connplex Cinemas Ltd
All →Connplex Cinemas Convertible Warrants
Connplex Cinemas allotted 8,00,000 convertible warrants at Rs 233.05 each to two non-promoter investors. The total allotment amount is Rs 18.64 Crore, with 25% payable on allotment.
- Value
- ₹18.64 Cr
- Execution
- Warrants convertible within 18 months of allotment, last conversion date April 29, 2028; unexercised warrants lapse by April 30, 2028
Connplex Cinemas Convertible Warrants
Connplex Cinemas Limited declared EGM voting results approving the issuance of 8,00,000 convertible warrants on a preferential basis to investors.
Connplex Cinemas Annual General Meeting
Connplex Cinemas Limited held its Extraordinary General Meeting on October 09, 2026, via video conferencing to transact business as per the meeting notice.
Connplex Cinemas Annual General Meeting
Connplex Cinemas Limited held its 11th Annual General Meeting on September 21, 2026. Shareholders approved resolutions covering financial statements, director appointments, ESOP amendments, and authorized capital increases.
Connplex Cinemas Annual General Meeting
Connplex Cinemas notices an EGM on October 9, 2026 to approve a ₹18.64 Crore preferential warrant issue. The 8,00,000 warrants at ₹233.05 each target non-promoter allottees.
- Value
- ₹18.64 Cr
Connplex Cinemas Capital Structure Change
Connplex Cinemas approved a preferential issue of 8,00,000 convertible warrants at ₹233.05 each, aggregating to ₹18.64 Crore. An EGM is scheduled for October 9, 2026.
- Value
- ₹18.64 Cr
Other management change announcements
All →Hindustan Bio Sciences Management Change
Hindustan Bio Sciences' Company Secretary and Compliance Officer Shailendra Vyas resigned, effective October 31, 2026. He cited an alternate career opportunity.
Tata Motors Management Change
B S R & Co. LLP resigned as statutory auditor, citing Iveco group alignment. Deloitte Haskins & Sells LLP was appointed to fill the vacancy.
Fortis Healthcare Management Change
Fortis Healthcare's Chief Growth & Innovation Officer, Dr. Ritu Garg, resigned effective close of business on October 31, 2026. The resignation is a senior management personnel change with no monetary impact stated.
Menon Pistons Management Change
Menon Pistons appointed Dr. D.T. Shirke as Non-Executive Independent Director for 36 months from 31 October 2026. Neha Marathe's independent directorship concluded on completion of tenure.
Tribhovandas Bhimji Zaveri Management Change
Tribhovandas Bhimji Zaveri appointed two Managing Directors and a Dy. CEO, and three executive directors resigned. The board reorganisation follows a change in control.
S A Tech Software India Management Change
S A Tech Software India disclosed that Company Secretary and Compliance Officer Arnika Choudhary resigned, effective close of business November 20, 2026. The company is hiring a replacement and will inform the exchanges once filled.